Sleep

If approved, daridorexant would become the first sleep medication to demonstrate an improvement in sleep and daytime functioning.

Increasing OSA severity was associated with increasing markers of obesity.

Sleep has increased since the beginning of the pandemic in college students, while social activity has decreased.

A pooled analysis of sleep disturbance-related outcomes showed the IgE inhibitor significantly benefits a burdensome symptom of CRSwNP.

Improvements for pain did not sustain at the 12 month follow-up.

New research show the novel DNRI benefits patients both adherent and not to their OSA primary therapy.

It is the first device designed to be used during a wakeful state.

New research expands on the understood link between sleep and ADHD-related behavior, and gives clinicians new therapeutic targets.

The drug is indicated in capsule form for adults and in a liquid formulation for children.

Nightware provides vibrations when it senses the user is having a nightmare.

In the study, investigators tested the impact of the study drug in a rerandomized patient population that previously received a placebo.

The rate of maternal clinical insomnia has increased from 11% prior to the pandemic to 23% during the COVID-19 pandemic.

Those who slept more than 10 hours or less than 4 hours per night declined faster than those who slept about 7 hours per night.

Investigators report on a post-hoc analysis of the EMPA-REG OUTCOME trial that assesses the efficacy of the SGLT-2 inhibitor in patients with obstructive sleep apnea.

Approximately 50% of patients with a mTBI who experience fatigue or sleep-wake disturbances 2 weeks following the injury continue to have problems at the 3 month mark.

The approval represents the second approved treatment of the conditions associated with narcolepsy patients at least 7 years old.

Both telemedicine and face-to-face therapy resulted in improved daytime function.

New research finds a 13% higher mortality rate for every 5% reduction in REM sleep.

Shorter nighttime sleep duration and later bedtime at 3.5 years old age were significantly associated with borderline personality disorder symptoms.

The presence of anxiety symptoms moderated most alterations in emotional processing observed following sleep restriction.

Recently, there has been a 7% increase in cannabis use from pregnant mothers.

Dr. Jennifer Martin explains how teenagers could benefit from a better sleep schedule and a later wake up time.

Increased technology use and alcohol consumption may be leading to some troubling trends in sleep.

The researchers suggested a significant link between second-hand smoke exposure and poor sleep quality, particularly among adolescents.

Individuals at 15 years old with depression experience struggles with both sleep patterns and sleep quality.

ADHD symptoms are highly comorbid with insomnia, restless leg syndrome, and snoring.

Sirimon Reutrakul, MD, discusses what providers should do based on the findings of a new study presented at ADA 2020.

Recent studies show efficacy and safety for both lemborexant and ozanimod.

In a new study, investigators discover insomnia severity could predict first-onset major depressive disorder.

Discussing the impact of COVID-19 on patients with neurologic conditions and how the rapid advent of telehealth has impacted interdisciplinary teams.